Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism - an in vitro study. Journal title: Pharmacological Reports Authors: Jacek Wójcikowski, Władysława Daniel Subject(s):
